A Phase Ii Study Of Intermittent Sorafenib With Bevacizumab (B) In B-Naive And Prior B-Exposed Epithelial Ovarian Cancer (Eoc) Patients.Jung-Min Lee,Christina M. Annunziata,John L. Hays,Peter L. Choyke,Liang Cao,Minshu Yu,Nilofer Saba Azad,Nicole Houston,Lori M. Minasian,Nicolas Gordon,Helen X. Chen,John J. Wright,Elise C. KohnJOURNAL OF CLINICAL ONCOLOGY（2014）引用 5|浏览10暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
